about
A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsMolecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisalGLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonistsIntraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K(+) current inhibition mediated by activation of caspases and GSK-3.Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase.A PrP(C)-caveolin-Lyn complex negatively controls neuronal GSK3β and serotonin 1B receptor.Pharmacological rescue of cortical synaptic and network potentiation in a mouse model for fragile X syndromeDicholine succinate, the neuronal insulin sensitizer, normalizes behavior, REM sleep, hippocampal pGSK3 beta and mRNAs of NMDA receptor subunits in mouse models of depression.Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 miceChronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.Silencing [Formula: see text] Rescues Tau Pathologies and Memory Deficits through Rescuing PP2A and Inhibiting GSK-3β Signaling in Human Tau Transgenic Mice.The association of glycogen synthase kinase-3beta (GSK-3β) gene polymorphism with kidney function in long-term lithium-treated bipolar patients.GSK-3β and memory formationHerpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-β protein accumulationNeurological characterization of mice deficient in GSK3α highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase.Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer's disease.Hydrogen Sulfide Prevents Synaptic Plasticity from VD-Induced Damage via Akt/GSK-3β Pathway and Notch Signaling Pathway in Rats.The ups and downs of bipolar disorder research.GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamineNMDA reduces Tau phosphorylation in rat hippocampal slices by targeting NR2A receptors, GSK3β, and PKC activities.Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.Modulation of Synaptic Plasticity in the Cortex Needs to Understand All the Players.GSK-3β Overexpression Alters the Dendritic Spines of Developmentally Generated Granule Neurons in the Mouse Hippocampal Dentate GyrusDynamic Akt/mTOR Signaling in Children with Autism Spectrum DisorderIntranasal siRNA administration reveals IGF2 deficiency contributes to impaired cognition in Fragile X syndrome mice.Understanding the relationship between GSK-3 and Alzheimer's disease: a focus on how GSK-3 can modulate synaptic plasticity processes.Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.Gephyrin phosphorylation in the functional organization and plasticity of GABAergic synapses.NMDA antagonists under investigation for the treatment of major depressive disorder.GSK-3β, a pivotal kinase in Alzheimer disease.Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseasesStressed and Inflamed, Can GSK3 Be Blamed?Anti-depressant-like effects of Jieyu chufan capsules in a mouse model of unpredictable chronic mild stressMyostatin-like proteins regulate synaptic function and neuronal morphology.Cortical Up states induce the selective weakening of subthreshold synaptic inputsNeurological functions of the masterswitch protein kinase - gsk-3.SPIN90 Modulates Long-Term Depression and Behavioral Flexibility in the HippocampusMembrane-tethered AKT kinase regulates basal synaptic transmission and early phase LTP expression by modulation of post-synaptic AMPA receptor level.Dynamic range of GSK3α not GSK3β is essential for bidirectional synaptic plasticity at hippocampal CA3-CA1 synapses.
P2860
Q26741164-B01C3EFC-BE73-457C-AB61-A6B8864A0CFBQ26783344-2D351D80-7BDE-43AC-971D-463DE37F646AQ27025974-38ABD858-7EE9-42C7-8A7B-1439C0A9676BQ27307787-1078AACE-34BF-47C5-A4D9-C94F00E5D67AQ30416883-82C0AEE4-B8CD-47B8-B4B9-162D952E2770Q30465622-7957B0DD-51A3-463F-83A6-4A4F38EE65B0Q30577662-01A27550-E8FC-4FCD-99AF-CBEBE085202DQ30580825-D8C0AA84-21FA-4B5E-B36A-E42A4D45D2C5Q30621713-AD7D8281-973D-400E-887A-80D0067811C6Q30645309-B9C37A28-679B-4EA5-9DA7-ACAC7128A86EQ30906677-DFBEA90A-DB64-4A64-BD63-78957A5D24E6Q33766526-F655F98E-0D13-49EF-B3B5-E4B04DDF1B75Q34502691-86F980C8-3F04-420C-9360-DC8E2BA0888CQ35904141-2CC8FC70-3E9D-47DE-BF0F-86E27F545DCDQ36187501-4A46286E-11C7-4C18-BA29-2F72DE630B63Q36898190-7D37B9CE-042B-476F-B1B1-B7450AB6F2C7Q37044978-F19C2AB7-92FF-476C-88C3-DB8B58B3C642Q37075664-63EB029D-FC2F-432C-B11F-1FF44C5C2B15Q37134759-3E4B0143-53F9-48F3-B6B8-6C71C1F1EF7AQ37172762-15B4CD15-F9E8-41FB-9BD0-5D02DD3204FCQ37375713-17DE5EFC-090F-4094-BD40-9F382C1BDE3BQ37417156-FBE971B4-E2A0-4F3E-A128-26222203DECBQ37617476-E9084D72-675C-433A-9220-E18F9371C237Q37692033-33C325AD-FE6B-4C4F-AEEB-A72080DD5F93Q37699604-8862D02D-6174-49FA-8B7F-CAAFEE68DE30Q37711788-D8807CFB-2D57-4DC5-BF06-6335AB98DC28Q38101982-8F32358A-B6EA-4D6F-9EDC-3CFE34DEB717Q38126701-0229684C-9AD0-4197-87D3-E35CEA9F1FA0Q38208292-41629A12-FA20-44C0-A654-478F3166AAEEQ38211107-F5490EDF-7911-4E92-A406-91BE36CBCA7DQ38218085-0FD580A2-1B3B-4132-99CD-6EE41D4E4A9AQ38272835-61EAE124-4C58-4143-8815-B85D46EBCA16Q39017112-1DF116F2-F9E4-48B0-B4C4-2DCCF06BEBFDQ41113416-45114E38-49A7-45A6-8A35-C56DF2F1A1B6Q41189411-A378AD8C-5633-41CF-98C4-796BD32D134BQ41689843-1BFAC6B9-6310-499D-8A93-DC55801EAB56Q42195030-80177350-4B8E-400E-B6C0-838F3E76F47EQ42363198-6B9397D1-4F51-49E4-BCB4-1CD5E398C164Q42491700-05F244A2-26C8-4DA0-A199-DBADC5185970Q43057335-C21D08C0-3814-49E6-8C6C-B3C8229D4AD2
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A pivotal role of GSK-3 in synaptic plasticity.
@ast
A pivotal role of GSK-3 in synaptic plasticity.
@en
type
label
A pivotal role of GSK-3 in synaptic plasticity.
@ast
A pivotal role of GSK-3 in synaptic plasticity.
@en
prefLabel
A pivotal role of GSK-3 in synaptic plasticity.
@ast
A pivotal role of GSK-3 in synaptic plasticity.
@en
P2093
P2860
P50
P356
P1476
A pivotal role of GSK-3 in synaptic plasticity
@en
P2093
Bong-Kiun Kaang
Celine S Nicolas
Changiz Taghibiglou
Clarrisa A Bradley
Graham L Collingridge
Zuner A Bortolotto
P2860
P356
10.3389/FNMOL.2012.00013
P577
2012-02-15T00:00:00Z